STOCK TITAN

Owlet, Inc. - OWLT STOCK NEWS

Welcome to our dedicated page for Owlet news (Ticker: OWLT), a resource for investors and traders seeking the latest updates and insights on Owlet stock.

Owlet, Inc. (NYSE: OWLT) is revolutionizing the digital parenting landscape by providing innovative solutions that bring peace of mind to parents. The company has developed a comprehensive digital platform that delivers real-time data and insights to help parents feel more calm and confident in their parenting journey. Its standout product, the Owlet Smart Sock, is the first baby monitor designed to track an infant's oxygen levels, heart rate, and sleep trends, providing critical information to ensure the well-being of newborns.

The Owlet Cam complements the Smart Sock, transforming any smartphone into a high-definition baby monitor. This combination is taken further with the Owlet Monitor Duo, which integrates the functionalities of both the Smart Sock and the Cam, offering a holistic monitoring solution. Additionally, Owlet offers the Owlet Dream Lab, an interactive program that helps parents establish healthy sleep habits for their infants through expert guidance and personalized plans.

In recent news, Owlet has announced a strategic partnership with Wheel, a leading virtual care platform. This collaboration will enhance Owlet’s offerings by providing caregivers with timely prescriptions for BabySat™, Owlet's FDA-cleared pulse oximeter for infants with pre-existing medical conditions. This integration with Wheel's extensive clinical network and infrastructure will significantly improve access to critical in-home monitoring services.

Owlet's financial condition remains robust as it continues to innovate and expand its product portfolio. The partnerships with leading healthcare providers and insurance companies further strengthen its market position by offering up to 100% reimbursement for BabySat through insurance or HSA/FSA programs.

Owlet’s vision of empowering parents with cutting-edge technology is reflected in their continuous efforts to integrate advanced features and seek strategic partnerships. Their commitment to improving infant care and parental confidence encapsulates their mission to transform the future of digital parenting.

Rhea-AI Summary

Owlet, Inc. will announce its first quarter 2024 financial results on May 6, 2024. The company's executives will host a conference call to discuss the results and provide a business update.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.45%
Tags
conferences earnings
-
Rhea-AI Summary
Wheel partners with Owlet to enhance virtual health services by providing timely prescriptions for BabySat, a smart infant monitoring device, empowering caregivers with in-home monitoring capabilities. Owlet's virtual care offering integrated with Wheel's platform allows for easy prescription access and insurance reimbursement, expanding access to critical care for infants transitioning home from the NICU.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) partners with Wheel to launch virtual telehealth services platform, revolutionizing infant care with digital healthcare solutions. The partnership aims to provide caregivers with timely prescriptions for Owlet's FDA-cleared infant pulse oximeter, BabySat, to monitor infant health effectively. The collaboration enhances access to innovative medical-grade monitoring, streamlining the process for caregivers to obtain BabySat through insurance reimbursement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
Rhea-AI Summary
Owlet, Inc. reported strong financial results for Q4 2023 and FY 2023, with revenue of $21.0 million and $54.0 million, respectively. The company's net loss decreased significantly by 65% in Q4 and 59% for FY 2023. Owlet's adjusted EBITDA loss also improved by 95% in Q4 and 76% for FY 2023, showcasing operational efficiency and cost reduction efforts. The company's gross margin increased to 47.1% in Q4 and 41.8% for FY 2023, indicating positive financial performance and growth. Owlet's CEO highlighted the successful commercialization of new medical devices, expansion into healthcare channels, and partnerships for reimbursement, setting a strong foundation for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.97%
Tags
-
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) announces a private placement of Series B preferred stock and warrants to raise $9 million after recent FDA clearances and strong Q4 results. The transaction offers a 25% premium to the market closing price. The company plans to issue 1.2 million common stock shares and warrants to investors, supporting its momentum in infant monitoring devices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.81%
Tags
none
-
Rhea-AI Summary
Owlet, Inc. (NYSE:OWLT) reports strong financial performance in Q4 2023 with Gross Sales of $32.9 million (up 114% YoY), Net Revenue of $21.0 million (up 75% YoY), Gross Margin at 47% (up over 1,900 bps YoY), Net Loss of $6.9 million (down 65% YoY), and adjusted EBITDA loss of $0.7 million (down 95% YoY). The company attributes the positive results to FDA clearances, cost reduction, and operational improvements. Despite non-recurring items impacting gross margin and EBITDA loss, Owlet anticipates continued growth in 2024 through new product commercialization and expanded distribution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.57%
Tags
conferences earnings
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) will participate in the 44th Annual Cowen Health Care Conference. Kurt Workman and Kate Scolnick will engage in a fireside chat on March 5, 2024, at 2:50 p.m. Eastern Time. Investors can access the live webcast on Owlet's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.57%
Tags
conferences
-
Rhea-AI Summary
Owlet, Inc. (NYSE:OWLT) announces the launch of Dream Sock and BabySat, two FDA-cleared medical devices for at-home infant monitoring. The devices provide real-time health insights with medical-grade accuracy and aim to help parents monitor their baby's well-being. Dream Sock is a pulse oximetry solution for infants without the need for a prescription, while BabySat is intended for infants with acute or chronic medical conditions. Both devices offer caregivers the ability to track vital signs and receive real-time notifications for low pulse rate and low oxygen levels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.21%
Tags
none
-
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) to participate in BTIG Digital Health Forum on November 20, 2023. Kurt Workman and Kate Scolnick to engage in fireside chat at 11 a.m. Eastern Time. 1x1 meetings with management available upon request through BTIG.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.61%
Tags
conferences
Rhea-AI Summary
Owlet, Inc. (NYSE:OWLT) Reports Q3 2023 Financial Results and FDA Authorization for Dream Sock®. Achieved revenues of $9.2 million, de novo FDA-authorization for Dream Sock, and a shift in Amazon revenue arrangement. Operating expenses reduced to $11.2 million compared to $26.4 million in 2022. Gross margin increased to 36.3% from 26.6% in the same period in 2022. Financial outlook to be discussed in the conference call on November 13, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.61%
Tags

FAQ

What is the current stock price of Owlet (OWLT)?

The current stock price of Owlet (OWLT) is $4.64 as of December 20, 2024.

What is the market cap of Owlet (OWLT)?

The market cap of Owlet (OWLT) is approximately 73.4M.

What is Owlet, Inc. known for?

Owlet, Inc. is known for its digital parenting platform, providing real-time data and insights to help parents monitor their infants' health.

What products does Owlet offer?

Owlet offers products like the Smart Sock, Owlet Cam, Monitor Duo, and Dream Lab, all designed to help parents monitor and care for their infants.

What is the Owlet Smart Sock?

The Smart Sock is a baby monitor that tracks an infant's oxygen levels, heart rate, and sleep trends, providing parents with critical health information.

How does the Owlet Cam work?

The Owlet Cam transforms any smartphone into a high-definition baby monitor, offering clear and reliable video monitoring of the infant.

What is the Owlet Monitor Duo?

The Monitor Duo combines the functionalities of the Smart Sock and Owlet Cam to provide comprehensive monitoring of an infant's health and environment.

What is the purpose of the Owlet Dream Lab?

The Dream Lab is an interactive program that guides parents in building healthy sleep habits for their infants through expert advice and personalized plans.

Who is Owlet's latest strategic partner?

Owlet’s latest strategic partner is Wheel, a virtual care platform that will help provide timely prescriptions for BabySat and enhance in-home monitoring services.

What is BabySat?

BabySat is Owlet's FDA-cleared pulse oximeter designed for infants with pre-existing medical conditions, allowing for effective health monitoring.

What financial benefits do parents get from Owlet products?

Owlet products like BabySat can offer up to 100% reimbursement through insurance or HSA/FSA programs, making them more accessible to parents.

How does Owlet contribute to the future of digital parenting?

Owlet contributes to the future of digital parenting by continuously innovating and integrating advanced technology to improve infant care and parental confidence.

Owlet, Inc.

NYSE:OWLT

OWLT Rankings

OWLT Stock Data

73.45M
14.30M
8.76%
46.64%
2.14%
Health Information Services
Measuring & Controlling Devices, Nec
Link
United States of America
LEHI